18^th World Congress on Gastroenterology -Therapeutics & Hepatology May 30-31, 2024 Vienna, Austria

Dr. Khalil Bitars is a postdoctoral research fellow at the Wake Forest Institute for Regenerative Medicine, has received the Early Career Investigators award from the American Gastroenterological Association (AGA) Institute Council.

Gastroenterology

Lu Liu completed her PhD in Monash University, Australia in 1998, and received the prestigious Mollie Holman Medal for best PhD thesis. From 1998-2005, she worked as a Post-doctoral research officer and senior research fellow in the gastrointestinal pharmacology research field at UNSW Australia. In 2006, she took up an academic position, became a Lecturer in the same institution and was promoted to Senior Lecturer in 2009. As a Chief Investigator, she has obtained research funding over $2.5 million from various grant bodies to support her research. She has established a track record of quality research outputs. She has published over 50 original research papers in high impact pharmacology, gastroenterology and urology journals and over 130 conference abstracts. Her research has been recognized both nationally and internationally. She received many awards and has been frequently invited to present at the conference symposia and seminars.

Pharmacology, Gastroenterology

Anil Kaul was graduated from Madras Medical College in Medicine, King Georges’ Medical College in Dentistry and in Public Health from University of Minnesota. He currently serves as the Director of High-Complexity Clinical Laboratories and a Faculty at Oklahoma State University-Center for Health Sciences. He has been awarded 6 patents and has published more than 50 scientific papers. He has served as Senior Health Advisor to the US Department of State and received “Expeditionary Service Award”. In 2014, he also received “Lifetime Achievement Award” at Global Health Summit and in 2008 he was named as Sony’s “Scientist of the Year Award”.

Global public health and Healthcare administration

Dimitar Tonev is a Experienced NASH specialist, a pharmaceutical physician with more than 15 years of both medical affairs and clinical development experience in HCV,HBV,HIV, autoimmune liver diseases, pandemic influenza as well as antibacterials and antimycotics.

Gastroenterology

Amanda Brisebois is an Internal Medicine and Palliative Care Specialist, who works in Edmonton, Alberta, Canada. She undertook her undergraduate education and Master’s degree at Queen’s University in Kingston, Ontario Canada. She completed her medical school training in Calgary, Alberta, and her General Medicine Specialty at the Mayo Clinic Rochester Minnesota, University of Calgary in Calgary, Alberta, and University of Alberta, in Edmonton. Since 2000, she has been practicing General Internal Medicine in both inpatient and outpatient settings. She also is a certified Palliative Care Specialist. Amanda Brisebois is an Internal Medicine and Palliative Care Specialist, who works in Edmonton, Alberta, Canada. She undertook her undergraduate education and Master’s degree at Queen’s University in Kingston, Ontario Canada. She completed her medical school training in Calgary, Alberta, and her General Medicine Specialty at the Mayo Clinic Rochester Minnesota, University of Calgary in Calgary, Alberta, and University of Alberta, in Edmonton. Since 2000, she has been practicing General Internal Medicine in both inpatient and outpatient settings. She also is a certified Palliative Care Specialist.

Gastroenterology